-

Endoluxe Introduces the First High-definition Wireless Camera With TowerTech

MANHATTAN BEACH, Calif.--(BUSINESS WIRE)--Endoluxe is proud to introduce the med-tech industry’s first high-definition, wireless endoscopic camera with TowerTech™. TowerTech™ provides the complete functionality of legacy endoscopy video platforms all built into the camera head.

Typical legacy endoscopic platforms require a bulky, wheeled base tower, camera head, camera processor, light source, bulky light cable, recorder, monitor, and a hazard-prone cable from the camera to the monitor. With Endoluxe TowerTech™, all the necessary visualization features and functionalities are conveniently built into the design award-winning camera head.

“Our goal in inventing the Endoluxe eVS was to eliminate the costly, complicated, and antiquated pieces of legacy endoscopy video platforms,” states Dr. Neal Patel, Endoluxe co-founder and Chief Innovation Officer. “We designed a platform that accommodates technological innovations that enhance procedure adoption, patient safety, and clinical outcomes.”

The Endoluxe eVS is the perfect camera system for all endoscopic procedures that utilize industry-standard rigid and flexible analogue scopes such as urology, gynecology, ENT, general surgery, and orthopedics. The handheld Orb replaces the legacy endoscopic tower with advanced, portable technology at 1/6 the cost.

Endoluxe is a world-class endoscopic video imaging organization based in the United States with worldwide distribution of its medical industry design award-winning Endoluxe Orb. The company is focused on reducing costs of legacy video platforms, enhancing procedure adoption, and improving patient outcomes through better therapy application. Endoluxe is committed to being a vendor-agnostic platform that allows customers to utilize their existing investment in traditional scopes and supporting devices, while taking advantage of future technological advancements utilizing our portable, integrated, and feature-laden platform at 1/6 the cost of legacy products. More information can be found at Endoluxe.com.

Contacts

Devon Bream
Endoluxe CEO
devon@endoluxe.com

Endoluxe


Release Summary
Endoluxe has released the healthcare industry’s first high-definition, wireless endoscopic camera with TowerTech™.
Release Versions

Contacts

Devon Bream
Endoluxe CEO
devon@endoluxe.com

Social Media Profiles
More News From Endoluxe

Endoluxe Announces Return of Founder Neal Patel, MD as CEO of Company

ATLANTA--(BUSINESS WIRE)--Endoluxe, Inc. announced today the return of founder Neal Patel, MD as CEO of the company following the departure of former CEO Devon Bream. Devon left the company to join GE Healthcare as President/General Manager, Invasive Cardiology Image Guided Therapies. Endoluxe thanked Devon for his tenure as CEO and for the significant growth he brought to the company since 2021. Devon will continue to serve as a business advisor during this transition period. Dr. Patel will ta...

Endoluxe Announces First ENT Procedures Using Endoluxe Vision System

MANHATTAN BEACH, Calif.--(BUSINESS WIRE)--Endoluxe congratulates Keith Matheny, MD, FARS, of Collin County Ear Nose & Throat in Frisco, TX, for being the first ear, nose and throat (ENT) surgeon in the U.S. to use the Endoluxe Vision System for endoscopic sinus surgery. Dr. Matheny is a nationally-known innovator in the field of Otolaryngology and has developed or been involved with several game-changing technologies around the ENT space over the past two decades. After completing seven End...

Endoluxe Announces Know-How Agreement With Mayo Clinic

MANHATTAN BEACH, Calif.--(BUSINESS WIRE)--Endoluxe announced today it has entered into a know-how agreement with Mayo Clinic to research the use of artificial intelligence and machine learning in the fight against bladder cancer. Mayo Clinic will utilize the Endoluxe Visualization System, a wireless endoscopic “smart” camera platform, and its unique edge computing attributes, which provide AI-powered clinical insights to clinicians and can lead to better patient outcomes. The novel Endoluxe tec...
Back to Newsroom